FDA Drug recall D-0222-2026
Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India,…
- FDA Drug
- Class III
- ongoing
- Published 2025-12-17
On 2025-12-17 the FDA classified a Class III recall of Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India,… by Glenmark Pharmaceuticals Usa, citing cross Contamination with Other Products.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0222-2026 |
| Classification | Class III |
| Status | ongoing |
| Initiated | 2025-11-18 |
| Published | 2025-12-17 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Glenmark Pharmaceuticals Usa |
| Distribution | US |
Product
Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for Avkare, Pulaski, TN 38478, Product of Italy, NDC 42291-874-90.
Reason
Cross Contamination with Other Products
Identifiers
| ndc | 42291-871-30 |
|---|---|
| ndc | 42291-872-90 |
| ndc | 42291-873-90 |
| ndc | 42291-874-90 |
| code_info | Lot# 17240988; Exp. 05/31/2026 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0222-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.